Truist Securities Maintains Buy on BKV, Raises Price Target to $34
Truist Securities analyst Gabe Daoud maintains BKV (NYSE:BKV) with a Buy and raises the price target from $33 to $34.
Stocks · News reference
U.S. stocks fell Wednesday, led by industrials. Crude inventories dropped unexpectedly, while Penguin Solutions and Lipocine surged; Caribou Biosciences
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Truist Securities analyst Gabe Daoud maintains BKV (NYSE:BKV) with a Buy and raises the price target from $33 to $34.
BKV (NYSE:BKV) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial
BKV stock rises after securing a power equipment deal backed by a major hyperscaler for a 1,200 MW Texas project.
Webull and Sentinel AI have launched a pilot program to provide public companies with direct engagement tools for retail investors through Webull's Corporate Connect service.
Webull Securities (Canada) Limited has introduced an AI-powered investing feature that allows users to connect their accounts to AI assistants for market research and trade execution.